VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012

Mar 16, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-03-14

Reporting Person: BOGER JOSHUA S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-14	Common Stock	G	34500	$0.00	Disposed	630949	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13286	Indirect
Common Stock	300000	Indirect

Footnotes

F1: Gift to trusts established for the benefit of Dr. Boger's family members.

F2: Common stock held in grantor retained annuity trusts.